Joe Mabel, Wikimedia CC
Joe Mabel, Wikimedia CC

Needle exchanges helped reduced NZ HIV transmissions

Embargoed until: Publicly released:

Between 1996 and 2018, New Zealand averaged just one HIV diagnosis per year among those who inject drugs, indicating needle exchanges have contributed to reducing transmission of the disease. Of more than 1650 people diagnosed with HIV during the 23-year study period, only 2.9 per cent of cases were in people who use needles for drugs. New Zealand's needle exchange programme, established in the late 1980s, provides free, sterile needs and advice to injecting drug users, which the researchers say has helped avoid the high rates of HIV found in other countries.

Journal/conference: Drug and Alcohol Review

Link to research (DOI): 10.1111/dar.13046

Organisation/s: University of Auckland, University of Otago

Funder: New Zealand AIDS Foundation Fellowship.

Media Release

From: University of Auckland

Low HIV infections in drug-users point to needle exchange success

New Zealand has avoided the high HIV rates seen among high-risk groups in other countries, a new study shows.

Sustained, extremely low levels of HIV transmission among people who inject drugs, including gay and bisexual men, reflect the success of needle-exchange programmes and other harm reduction measures, researchers say.

The new study shows in the years from 1996 to 2018, Aotearoa New Zealand averaged just one HIV diagnosis per year among both heterosexual people who inject drugs, and the most at-risk group in the study: gay and bisexual men who inject drugs.

In the 23-year period covered, 1653 people were diagnosed with HIV (excluding cases contracted overseas). The most common mode of transmission was sex between men (77.4 percent), followed by sex between men and women (14.2 percent). Only 2.9 percent of the cases were in people who injected drugs.

The lead author is Dr Peter Saxton from the University of Auckland’s Centre for Addiction Research. “Our study shows that HIV has been effectively controlled among most people who inject drugs in New Zealand, and this record has been sustained over multiple decades,” he says.

“The fact that HIV diagnoses have remained so low for so long in New Zealand suggests that effective interventions have reached the majority of people who inject drugs. These include needle exchange programmes, condoms, HIV testing and treatments. It’s critical that these services continue, and engage better with those who continue to find themselves at risk of contracting HIV.”

Established in the late 1980s, the New Zealand Needle Exchange Programme is a network of 20 regional outlets and 180 pharmacies and alternative outlets who supply free, sterile needles and empathetic advice and information to injecting drug-users. It’s an example of the harm reduction approach to drug use, which seeks to work alongside people to improve their health and wellbeing without coercion, judgement or discrimination.

Co-author Dr Geoff Noller is a researcher with the programme. “There is no question that the inception 30 years ago of a national needle exchange programme, a world first, has allowed New Zealand to maintain one of the lowest rates globally of HIV infection among people who inject drugs: consistently below one percent,” he says.

“But we have to remain on our toes. HIV is transmitted very easily by sharing unsterilized injecting equipment, and the potential for clusters of infection to occur quickly is always there. Ongoing resourcing of harm reduction strategies such as needle exchange, safe sex options and HIV surveillance in at-risk populations is vital.”

Co-author Dr Sue McAllister, leader of the AIDS Epidemiology Group at University of Otago, says: “Our data suggests New Zealand has one of the smallest epidemics among people who inject drugs internationally. However, our findings that 20 percent of gay and bisexual men who inject drugs had HIV, and that in 2018, six gay and bisexual men who inject drugs were diagnosed with HIV, show there is no room for complacency.”

Expert Reaction

These comments have been collated by the Science Media Centre to provide a variety of expert perspectives on this issue. Feel free to use these quotes in your stories. Views expressed are the personal opinions of the experts named. They do not represent the views of the SMC or any other organisation unless specifically stated.

Dr Rhys Ponton is a Professional Teaching Fellow at the School of Pharmacy, University of Auckland.

This study further demonstrates the benefit and effectiveness of needle exchange in reducing the spread of HIV. The dedicated needle exchange services, alongside the wide network of community pharmacy needle exchange providers, are a key part of New Zealand’s successful approach to this public health issue.

Last updated: 26 Feb 2020 11:11am
Declared conflicts of interest:
I am currently working alongside Dr Geoff Noller and Kathryn Leafe on another project involving needle exchange/drug injecting. I work alongside David Newcombe and collaborate on a couple of unrelated projects. Peter Saxton is based at the University of Auckland and we have previously discussed future collaboration (but are not currently working on anything as a team).
Prof Mark Henrickson is Professor of Social Work at Massey University, Auckland.

It is very pleasing to see New Zealand HIV research on men who have sex with men (MSM) who also inject drugs. This research methodology is sound and reinforces the value of New Zealand’s early policy on decriminalising possession of injecting equipment and funding syringe access schemes in response to HIV. As a result, the HIV incidence in injecting drug users, and in MSM who inject drugs in particular, has been remarkably low over the history of the epidemic in New Zealand. This is something about which New Zealand can be very satisfied. The findings of the present study clearly demonstrate the value of putting what can only be called common-sense policy interventions—responding to what is— over ideologically pure interventions that set health policy only based on what some groups think should be ideal human behaviour.

Remembering that all injecting drugs are very likely to be illegal, creating an intervention strategy—access to needles and syringes—based on public health rather than criminalising the behaviour has worked. The study, therefore, has implications for testing of drugs at festivals and other events, the full implementation of the 2013 Psychoactive Substances (the ‘legal highs’) Act, for the upcoming cannabis referendum, and indeed for a health-driven (rather than criminalising) approach to recreational drug use in general. The history of drug policies over the centuries has largely been driven by responses to socially stigmatised people who use drugs, rather than rational responses to the drugs themselves. This study suggests that when policymakers make rational choices led by concerns for public health then those policies work.

Nevertheless, there are some concerning findings in this study, notably the over-representation of Māori who have sex with men and also inject drugs and are infected with HIV. The present study highlights the lack of research in this area, and the apparent inability of the public health, iwi health, and HIV-prevention infrastructures to reach Māori. Previous research has found that Māori MSM are also more likely than tauiwi MSM to have sex with women; the disproportionately large number of Māori living with HIV is therefore very concerning for several reasons. It is not adequate to say that we do not know why Māori MSM who also inject drugs are overrepresented: even though the actual numbers are small, this finding signals the apparent systemic failure of existing prevention responses to attend to Māori. Funding for research in this population and appropriate interventions are urgently required.

In addition, that the group of recent injectors tends to be younger is concerning: clearly there must be additional injection drug prevention education and intervention targeted at younger MSM. New Zealand has well-developed domestic methamphetamine manufacture and distribution networks, and public responses must realistically consider health risks and responses as well as the criminality of these networks.

Last updated: 26 Feb 2020 11:07am
Declared conflicts of interest:
No conflict of interest.

News for:

New Zealand

Media contact details for this story are only visible to registered journalists.